The Role of Tranexamic Acid in Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass in Neonates
| Status: | Withdrawn |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/2/2017 |
| Start Date: | July 2013 |
| End Date: | June 2014 |
This is an observational, prospective study to evaluate the role of tranexamic acid in
reducing blood transfusion in neonates undergoing cardiopulmonary bypass.
reducing blood transfusion in neonates undergoing cardiopulmonary bypass.
Inclusion Criteria:
- All neonates undergoing arterial switch or aortic arch procedure utilizing
cardiopulmonary bypass (CPB).
Exclusion Criteria:
- Jehovah's witness patients.
We found this trial at
1
site
Nationwide Children's Hospital At Nationwide Children’s, we are creating the future of pediatric health care....
Click here to add this to my saved trials
